Search

Robert W. Downs

Examiner (ID: 17152)

Most Active Art Unit
2308
Art Unit(s)
2762, 4762, 2309, 2308, 2165
Total Applications
581
Issued Applications
448
Pending Applications
24
Abandoned Applications
109

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10489822 [patent_doc_number] => 20150374843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/689537 [patent_app_country] => US [patent_app_date] => 2015-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 68508 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14689537 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/689537
MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS Apr 16, 2015 Abandoned
Array ( [id] => 12858172 [patent_doc_number] => 20180177898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => GLUCOSE ANALOGS FOR DIAGNOSIS OF DISEASE STATES [patent_app_type] => utility [patent_app_number] => 15/129255 [patent_app_country] => US [patent_app_date] => 2015-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5560 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15129255 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/129255
Glucose analogs for diagnosis states Mar 25, 2015 Issued
Array ( [id] => 10311670 [patent_doc_number] => 20150196673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'ANTICANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 14/669313 [patent_app_country] => US [patent_app_date] => 2015-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14484 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14669313 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/669313
Anticancer therapy Mar 25, 2015 Issued
Array ( [id] => 16413334 [patent_doc_number] => 10821196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Substrate based PET imaging agents [patent_app_type] => utility [patent_app_number] => 14/643071 [patent_app_country] => US [patent_app_date] => 2015-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22369 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14643071 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/643071
Substrate based PET imaging agents Mar 9, 2015 Issued
Array ( [id] => 11204079 [patent_doc_number] => 09433690 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-09-06 [patent_title] => 'Radiopharmaceutical solutions with advantageous properties' [patent_app_type] => utility [patent_app_number] => 14/632849 [patent_app_country] => US [patent_app_date] => 2015-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11651 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14632849 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/632849
Radiopharmaceutical solutions with advantageous properties Feb 25, 2015 Issued
Array ( [id] => 11326111 [patent_doc_number] => 20160356723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening' [patent_app_type] => utility [patent_app_number] => 15/114692 [patent_app_country] => US [patent_app_date] => 2015-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17049 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114692 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/114692
Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening Jan 26, 2015 Abandoned
Array ( [id] => 11382870 [patent_doc_number] => 20170008926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'RARE EARTH MATERIAL-BINDING PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/113287 [patent_app_country] => US [patent_app_date] => 2015-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12588 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113287 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/113287
Rare earth material-binding peptide and use thereof Jan 20, 2015 Issued
Array ( [id] => 10332002 [patent_doc_number] => 20150217006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'AL-F-18-LABELED, AL-F-19-LABELED AND GA-68-LABELED GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-ANTAGONISTS FOR IMAGING OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/599816 [patent_app_country] => US [patent_app_date] => 2015-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15895 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14599816 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/599816
AL-F-18-LABELED, AL-F-19-LABELED AND GA-68-LABELED GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-ANTAGONISTS FOR IMAGING OF PROSTATE CANCER Jan 18, 2015 Abandoned
Array ( [id] => 10305400 [patent_doc_number] => 20150190400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'THIOFLAVIN DERIVATIVES FOR USE IN THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER\'S DISEASE AND IN VIVO IMAGING AND PREVENTION OF AMYLOID DEPOSITION' [patent_app_type] => utility [patent_app_number] => 14/595949 [patent_app_country] => US [patent_app_date] => 2015-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15655 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14595949 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/595949
Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition Jan 12, 2015 Issued
Array ( [id] => 12322893 [patent_doc_number] => 09943606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents [patent_app_type] => utility [patent_app_number] => 14/594844 [patent_app_country] => US [patent_app_date] => 2015-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12873 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594844 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/594844
Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents Jan 11, 2015 Issued
Array ( [id] => 13278465 [patent_doc_number] => 10150804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-11 [patent_title] => Compositions and methods for imaging cancer [patent_app_type] => utility [patent_app_number] => 15/109551 [patent_app_country] => US [patent_app_date] => 2015-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 10719 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109551 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/109551
Compositions and methods for imaging cancer Jan 1, 2015 Issued
Array ( [id] => 11115327 [patent_doc_number] => 20160312301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'MICRORNA BIOMARKERS FOR OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 15/105763 [patent_app_country] => US [patent_app_date] => 2014-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12423 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105763 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/105763
MICRORNA BIOMARKERS FOR OVARIAN CANCER Dec 21, 2014 Abandoned
Array ( [id] => 10297644 [patent_doc_number] => 20150182644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/579157 [patent_app_country] => US [patent_app_date] => 2014-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19615 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579157 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/579157
Compounds and methods for the detection of TRPV-6 cancers and drug delivery Dec 21, 2014 Issued
Array ( [id] => 11106293 [patent_doc_number] => 20160303263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'RADIOTRACER COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 15/102952 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8986 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102952 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/102952
Radiotracer compositions and methods Dec 17, 2014 Issued
Array ( [id] => 12015853 [patent_doc_number] => 09808541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-07 [patent_title] => 'Thioflavin derivatives for use in antemortem diagnosis of Alzheimer\'s disease and in vivo imaging and prevention of amyloid deposition' [patent_app_type] => utility [patent_app_number] => 14/571082 [patent_app_country] => US [patent_app_date] => 2014-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 14189 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571082 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/571082
Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition Dec 14, 2014 Issued
Array ( [id] => 11106289 [patent_doc_number] => 20160303258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS' [patent_app_type] => utility [patent_app_number] => 15/100883 [patent_app_country] => US [patent_app_date] => 2014-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35470 [patent_no_of_claims] => 167 [patent_no_of_ind_claims] => 75 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100883 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/100883
COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS Dec 2, 2014 Abandoned
Array ( [id] => 11077168 [patent_doc_number] => 20160274132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'MARKER OF CELL DEATH' [patent_app_type] => utility [patent_app_number] => 15/037360 [patent_app_country] => US [patent_app_date] => 2014-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17107 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037360 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/037360
Marker of cell death Nov 26, 2014 Issued
Array ( [id] => 17194187 [patent_doc_number] => 11162937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-02 [patent_title] => Patient selection method for inflammation [patent_app_type] => utility [patent_app_number] => 15/037793 [patent_app_country] => US [patent_app_date] => 2014-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 41 [patent_no_of_words] => 21245 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037793 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/037793
Patient selection method for inflammation Nov 18, 2014 Issued
Array ( [id] => 12962617 [patent_doc_number] => 09873721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Fluorescent fusion protein [patent_app_type] => utility [patent_app_number] => 14/543238 [patent_app_country] => US [patent_app_date] => 2014-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4158 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14543238 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/543238
Fluorescent fusion protein Nov 16, 2014 Issued
Array ( [id] => 14818529 [patent_doc_number] => 10406250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Suicide contrast agents targeting HIV reservoirs for theranostic eradication [patent_app_type] => utility [patent_app_number] => 15/036512 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 33 [patent_no_of_words] => 20570 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036512 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/036512
Suicide contrast agents targeting HIV reservoirs for theranostic eradication Nov 13, 2014 Issued
Menu